The prevalence and association between avoidant/restrictive food intake disorder-(ARFID) and disorders of gut-brain interaction (DGBI): a scoping review.
Niloufar Rezaei, Sina Tamaskani Zahedi, Parisa Hajihashemi, Hamid Nasiri-Dehsorkhi, Arefeh Zamani, Amrollah Ebrahimi, Peyman Adibi, David Armstrong
{"title":"The prevalence and association between avoidant/restrictive food intake disorder-(ARFID) and disorders of gut-brain interaction (DGBI): a scoping review.","authors":"Niloufar Rezaei, Sina Tamaskani Zahedi, Parisa Hajihashemi, Hamid Nasiri-Dehsorkhi, Arefeh Zamani, Amrollah Ebrahimi, Peyman Adibi, David Armstrong","doi":"10.1080/10640266.2025.2519904","DOIUrl":null,"url":null,"abstract":"<p><p>Avoidant/restrictive food intake disorder (ARFID) is characterized by restrictive and avoidant feeding and eating behaviors not linked to body weight or shape concerns, potentially exacerbated by disorders of gut-brain interaction (DGBI). This scoping review was conducted to systematically map the literature on ARFID and DGBI to determine the prevalence of ARFID in DGBI, the prevalence of DGBI in ARFID patients, and the association between these disorders. Online databases, including PubMed, Scopus, and Web of Science were systematically reviewed from 2013 to April 2025. Studies that reported the prevalence of ARFID in DGBI groups, the prevalence of DGBI in ARFID individuals, and examined the association between ARFID and DGBI were included. Out of 4,085 screened sources, nine studies met the inclusion criteria. The prevalence of ARFID in patients with DGBI ranged from 13.2% to 40%. Individuals with ARFID showed a higher risk for DGBI and its symptoms compared to controls. This review summarized the prevalence of ARFID in DGBI patients, and the association between these disorders. Limitations include small sample sizes and inconsistencies in diagnostic scales. Larger-scale research is needed to clarify the association, along with improved assessment tools for accurate diagnosis of ARFID and DGBI.</p>","PeriodicalId":48835,"journal":{"name":"Eating Disorders","volume":" ","pages":"1-19"},"PeriodicalIF":3.5000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eating Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10640266.2025.2519904","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Avoidant/restrictive food intake disorder (ARFID) is characterized by restrictive and avoidant feeding and eating behaviors not linked to body weight or shape concerns, potentially exacerbated by disorders of gut-brain interaction (DGBI). This scoping review was conducted to systematically map the literature on ARFID and DGBI to determine the prevalence of ARFID in DGBI, the prevalence of DGBI in ARFID patients, and the association between these disorders. Online databases, including PubMed, Scopus, and Web of Science were systematically reviewed from 2013 to April 2025. Studies that reported the prevalence of ARFID in DGBI groups, the prevalence of DGBI in ARFID individuals, and examined the association between ARFID and DGBI were included. Out of 4,085 screened sources, nine studies met the inclusion criteria. The prevalence of ARFID in patients with DGBI ranged from 13.2% to 40%. Individuals with ARFID showed a higher risk for DGBI and its symptoms compared to controls. This review summarized the prevalence of ARFID in DGBI patients, and the association between these disorders. Limitations include small sample sizes and inconsistencies in diagnostic scales. Larger-scale research is needed to clarify the association, along with improved assessment tools for accurate diagnosis of ARFID and DGBI.
回避/限制性食物摄入障碍(ARFID)的特征是与体重或体型无关的限制性和回避性进食行为,可能因肠-脑相互作用障碍(DGBI)而加剧。本综述旨在系统地绘制ARFID和DGBI的文献图谱,以确定ARFID在DGBI中的患病率、ARFID患者中DGBI的患病率以及这些疾病之间的关联。从2013年到2025年4月,系统地回顾了PubMed、Scopus和Web of Science等在线数据库。研究报告了ARFID在DGBI组中的患病率,ARFID个体中DGBI的患病率,以及ARFID和DGBI之间的关系。在4085个筛选来源中,有9个研究符合纳入标准。DGBI患者ARFID的患病率为13.2%至40%。ARFID患者与对照组相比,DGBI及其症状的风险更高。本文综述了ARFID在DGBI患者中的患病率,以及这些疾病之间的关系。局限性包括样本量小和诊断量表不一致。需要更大规模的研究来澄清这种关联,以及改进评估工具以准确诊断ARFID和DGBI。
期刊介绍:
Eating Disorders is contemporary and wide ranging, and takes a fundamentally practical, humanistic, compassionate view of clients and their presenting problems. You’ll find a multidisciplinary perspective on clinical issues and prevention research that considers the essential cultural, social, familial, and personal elements that not only foster eating-related problems, but also furnish clues that facilitate the most effective possible therapies and treatment approaches.